The role of survivin splice variants in pancreatic ductal adenocarcinoma Gemcitabine resistance

被引：1
|
作者：
Kabagwira, Janviere [1 ]
Gonda, Amber [1 ]
Kwong, Mei Li [1 ]
机构：
[1] Loma Linda Univ, Loma Linda, CA 92350 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3021
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Mikamori, Manabu
    Yamada, Daisaku
    Eguchi, Hidetoshi
    Hasegawa, Shinichiro
    Kishimoto, Tomoya
    Tomimaru, Yoshito
    Asaoka, Tadafumi
    Noda, Takehiro
    Wada, Hiroshi
    Kawamoto, Koichi
    Gotoh, Kunihito
    Takeda, Yutaka
    Tanemura, Masahiro
    Mori, Masaki
    Doki, Yuichiro
    SCIENTIFIC REPORTS, 2017, 7
  • [22] MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
    Manabu Mikamori
    Daisaku Yamada
    Hidetoshi Eguchi
    Shinichiro Hasegawa
    Tomoya Kishimoto
    Yoshito Tomimaru
    Tadafumi Asaoka
    Takehiro Noda
    Hiroshi Wada
    Koichi Kawamoto
    Kunihito Gotoh
    Yutaka Takeda
    Masahiro Tanemura
    Masaki Mori
    Yuichiro Doki
    Scientific Reports, 7
  • [23] Modified FOLFIRINOX superior to gemcitabine in resected pancreatic ductal adenocarcinoma
    Thoma C.
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 (3) : 140 - 140
  • [24] FGFR inhibitors enhance gemcitabine sensitivity in pancreatic ductal adenocarcinoma
    Lin, Qingxiang
    Chaudhuri, Tista Roy
    Straubinger, Ninfa L.
    Ma, Wen Wee
    Straubinger, Robert M.
    CANCER RESEARCH, 2017, 77
  • [25] Role of epigenetics in pancreatic ductal adenocarcinoma
    Pandey, Somnath
    Gupta, Vineet K.
    Lavania, Shweta P.
    EPIGENOMICS, 2023, 15 (02) : 89 - 110
  • [26] Histological variants of pancreatic ductal adenocarcinoma: a survival analysis
    Bengtsson, Axel
    Andersson, Roland
    Ansari, Daniel
    LANGENBECKS ARCHIVES OF SURGERY, 2024, 409 (01)
  • [27] Pancreatic Ductal Adenocarcinoma and Its Variants: Pearls and Perils
    Schawkat, Khoschy
    Manning, Maria A.
    Glickman, Jonathan N.
    Mortele, Koenraad J.
    RADIOGRAPHICS, 2020, 40 (05) : 1219 - 1239
  • [28] Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma
    Shah, Ashu
    Ganguly, Koelina
    Rauth, Sanchita
    Sheree, Shamema S.
    Khan, Imran
    Ganti, Apar K.
    Ponnusamy, Moorthy P.
    Kumar, Sushil
    Jain, Maneesh
    Batra, Surinder K.
    DRUG RESISTANCE UPDATES, 2024, 77
  • [29] YAP-LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
    Li, Yecheng
    Wang, Xiaolong
    Yu, Hongpei
    Cao, Jinming
    Xie, Jiaming
    Zhou, Jinhong
    Feng, Zhenyu
    Chen, Wei
    MOLECULAR CARCINOGENESIS, 2024, 63 (10) : 1953 - 1966
  • [30] Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460
    Zhu, Xiao-Xu
    Li, Jian-Hui
    Ni, Xuhao
    Wu, Xiao
    Hou, Xun
    Li, Ya-Xiong
    Li, Shi-Jin
    Zhao, Wei
    Yin, Xiao-Yu
    CANCER SCIENCE, 2022, 113 (11) : 3735 - 3750
12345